The immunosuppressant, 4-deoxypyridoxine (DOP), demonstrates novel neuroprotective effects in the acute MPTP model of Parkinson's disease
Publication/Presentation Date
2007
Volume
13
Issue
2
First Page
142
Last Page
142
Published In/Presented At
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
Department(s)
Administration and Leadership
Document Type
Article
COinS